PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1129
https://www.valueinhealthjournal.com/article/S1098-3015(12)02842-2/fulltext
Title :
PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02842-2&doi=10.1016/j.jval.2012.08.1129
First page :
A396
Section Title :
Infection
Open access? :
No
Section Order :
631